mipa-cocoyl sarcosinate은 임신 중 안전한가요?
No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
성분
mipa-cocoyl sarcosinate
알려진 위험 없음100
/100
0
Pregnancy-safe products containing mipa-cocoyl sarcosinate
Related ingredients
Frequently asked questions
- mipa-cocoyl sarcosinate은 임신 중 안전한가요?
- No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
- mipa-cocoyl sarcosinate은 모유 수유 중 안전한가요?
- Same rationale as pregnancy: no evidence of reproductive/developmental hazard or mechanism suggesting lactation/transfer concerns; CIR concluded sarcosinates are safe as used. No studies showing placental or milk transfer or effects on neonates were found.
- mipa-cocoyl sarcosinate은 아기 피부에 안전한가요?
- No specific developmental/infant toxicity evidence; CIR states sarcosinates are safe in rinse‑off and at limited concentrations in leave‑on use. Dermal absorption data are limited, but sarcosinate surfactants are rinsed and not described as non‑absorbable; per the scoring rules, adult exposure scored 0 and infant exposure increased by +1 because infant skin has higher surface‑area‑to‑weight and an immature barrier. No infant‑specific hazard or mechanism data were found.
- VeriMom은 mipa-cocoyl sarcosinate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 mipa-cocoyl sarcosinate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 mipa-cocoyl sarcosinate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.


